Quick Answer
Alignment Healthcare, Inc. reported Operating Income Loss of -$101.56 million for the year ending 2024.
- Alignment Healthcare, Inc. showed an increase of +20.5% in Operating Income Loss from 2023 to 2024.
- This data is from Alignment Healthcare, Inc.'s annual report (Form 10-K), filed with the SEC on February 27, 2025.
- XBRL data for this metric is available from 2019 to 2024 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: -$5.12 million | Q2 2020: $12.59 million | Q3 2020: $15.06 million | Q1 2021: -$52.66 million | Q2 2021: -$40.49 million | Q3 2021: -$41.45 million | Q1 2022: -$36.48 million | Q2 2022: -$6.65 million | Q3 2022: -$33.41 million | Q1 2023: -$32.49 million | Q2 2023: -$23.66 million | Q3 2023: -$29.76 million | Q1 2024: -$41.11 million | Q2 2024: -$18.38 million | Q3 2024: -$19.52 million | Q1 2025: -$5.39 million | Q2 2025: $22.75 million | Q3 2025: $7.68 million.
- Over the full 6 years of available data (2019 to 2024), Alignment Healthcare, Inc.'s Operating Income Loss has declined by 244.4%.
- Historical annual values: Fiscal year 2024: -$101.56 million | Fiscal year 2023: -$127.82 million | Fiscal year 2022: -$128.64 million | Fiscal year 2021: -$178.07 million | Fiscal year 2020: -$5.26 million | Fiscal year 2019: -$29.48 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: